Cargando…

Quantitative CT assessment of bone mineral density in dogs with hyperadrenocorticism

Canine hyperadrenocorticism (HAC) is one of the most common causes of general osteopenia. In this study, quantitative computed tomography (QCT) was used to compare the bone mineral densities (BMD) between 39 normal dogs and 8 dogs with HAC (6 pituitary-dependent hyperadrenocorticism [PDH]; pituitary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Donghoon, Lee, Youngjae, Choi, Wooshin, Chang, Jinhwa, Kang, Ji-Houn, Na, Ki-Jeong, Chang, Dong-Woo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Veterinary Science 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701747/ https://www.ncbi.nlm.nih.gov/pubmed/26040613 http://dx.doi.org/10.4142/jvs.2015.16.4.531

Ejemplares similares

Correlation between caudal pulmonary artery diameter to body surface area ratio and echocardiography-estimated systolic pulmonary arterial pressure in dogs
por: Lee, Youngjae, et al.
Publicado: (2016)

Serum Cortisol Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism and Atypical Hyperadrenocorticism
por: Frank, L.A., et al.
Publicado: (2014)

Serum Adipokine Concentrations in Dogs with Naturally Occurring Pituitary‐Dependent Hyperadrenocorticism
por: Cho, K.‐D., et al.
Publicado: (2013)

Ultrasonographic evaluation of skin thickness in small breed dogs with hyperadrenocorticism
por: Heo, Seonghun, et al.
Publicado: (2018)

Successful treatment of occult hyperadrenocorticism with mitotane but not trilostane in a dog
por: Park, Su‐Min, et al.
Publicado: (2021)

Trismus due to myotonia associated with hyperadrenocorticism in a dog
por: YOKOTA, Shunya, et al.
Publicado: (2023)

Relationship of serum leptin concentration with pituitary‐dependent hyperadrenocorticism and cholestatic disease in dogs
por: Lee, S., et al.
Publicado: (2019)

Cortisol Concentrations in Well‐Regulated Dogs with Hyperadrenocorticism Treated with Trilostane
por: Midence, J.N., et al.
Publicado: (2015)

Laboratory assessment of trilostane treatment in dogs with pituitary‐dependent hyperadrenocorticism
por: Arenas Bermejo, Carolina, et al.
Publicado: (2020)

Suspected spontaneous hyperadrenocorticism in a young experimental beagle dog
por: Obara, Ryo D., et al.
Publicado: (2021)

Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism
por: Nam, Sookin, et al.
Publicado: (2021)

Prediction of bone mineral density in CT using deep learning with explainability
por: Kang, Jeong-Woon, et al.
Publicado: (2023)

Comparison of 2 Doses for ACTH Stimulation Testing in Dogs Suspected of or Treated for Hyperadrenocorticism
por: Aldridge, C., et al.
Publicado: (2016)

Effect of Trilostane and Mitotane on Aldosterone Secretory Reserve in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Reid, L.E., et al.
Publicado: (2014)

Antibody Response to Canine Parvovirus Vaccination in Dogs with Hyperadrenocorticism Treated with Trilostane
por: Bergmann, Michèle, et al.
Publicado: (2020)

Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
por: García San José, Paula, et al.
Publicado: (2020)

Erratum for “Evaluation of compounded trilostane packets for dogs with naturally occurring hyperadrenocorticism”
Publicado: (2022)

Evaluation of left ventricular function with cardiac magnetic resonance imaging and echocardiography after administration of dobutamine and esmolol in healthy beagle dogs
por: JEONG, Hyeryoung, et al.
Publicado: (2021)

Canine Pancreatic‐Specific Lipase Concentrations in Clinically Healthy Dogs and Dogs with Naturally Occurring Hyperadrenocorticism
por: Mawby, D.I., et al.
Publicado: (2014)

A Preliminary Study of the Effect of Hyperadrenocorticism on Calcium and Phosphate Concentrations, Parathyroid Hormone and Markers of Bone Turnover in Dogs
por: Mooney, Carmel T., et al.
Publicado: (2020)

Effect of Trilostane on Hormone and Serum Electrolyte Concentrations in Dogs with Pituitary‐Dependent Hyperadrenocorticism
por: Griebsch, C., et al.
Publicado: (2013)

Metformin reduces insulin resistance and the tendency toward hyperglycaemia and dyslipidaemia in dogs with hyperadrenocorticism
por: Miceli, Diego Daniel, et al.
Publicado: (2018)

Erratum for Prevalence and risk factors associated with systemic hypertension in dogs with spontaneous hyperadrenocorticism
Publicado: (2020)

Survival analysis of 219 dogs with hyperadrenocorticism attending primary care practice in England
por: Schofield, Imogen, et al.
Publicado: (2020)

Case Report: Non-traumatic Unilateral Forelimb Arterial Thrombosis Associated With Hyperadrenocorticism in a Dog
por: Eom, Tae-Yoon, et al.
Publicado: (2021)

Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study
por: Oo, Thandar, et al.
Publicado: (2022)

QCBCT-NET for direct measurement of bone mineral density from quantitative cone-beam CT: a human skull phantom study
por: Yong, Tae-Hoon, et al.
Publicado: (2021)

Case report: Central-pituitary hypothyroidism concurrent with hyperadrenocorticism without pituitary macroadenoma in a Miniature Schnauzer dog
por: Chae, Yeon, et al.
Publicado: (2023)

CT and MR for bone mineral density and trabecular bone score assessment in osteoporosis evaluation
por: Lee, Haein, et al.
Publicado: (2023)

Evaluation of individual low‐dose dexamethasone suppression test patterns in naturally occurring hyperadrenocorticism in dogs
por: Bennaim, Michael, et al.
Publicado: (2018)

The effect of 1 year of trilostane treatment on peripheral lymphocyte subsets in dogs with pituitary-dependent hyperadrenocorticism
por: ODA, Hitomi, et al.
Publicado: (2016)

Effects of Interval Exercise Training on Serum Biochemistry and Bone Mineral Density in Dogs
por: Lee, Hae Sung, et al.
Publicado: (2021)

Dual-Energy CT-Based Bone Mineral Density Has Practical Value for Osteoporosis Screening around the Knee
por: Choi, Keun Young, et al.
Publicado: (2022)

Bone Mineral Density in Prediabetic Men
por: Lee, Ju Hee, et al.
Publicado: (2010)

Associations among systemic blood pressure, microalbuminuria and albuminuria in dogs affected with pituitary- and adrenal-dependent hyperadrenocorticism
por: Lien, Yu-Hsin, et al.
Publicado: (2010)

Assessment of left ventricular function by two-dimensional speckle-tracking echocardiography in small breed dogs with hyperadrenocorticism
por: Chen, Hung-Yin, et al.
Publicado: (2014)

Clinical Relationship between Cholestatic Disease and Pituitary‐Dependent Hyperadrenocorticism in Dogs: A Retrospective Case Series
por: Kim, K.‐h., et al.
Publicado: (2017)

Changes in systolic blood pressure in dogs with pituitary dependent hyperadrenocorticism during the first year of trilostane treatment
por: García San José, Paula, et al.
Publicado: (2020)

Three Cases of Transtracheal Catheter Oxygenation for Postoperative Dyspnoea with Pituitary-Dependent Hyperadrenocorticism in Dogs Treated by Surgery
por: Tanaka, Sachiyo, et al.
Publicado: (2022)

Serum Bile Acids Concentrations and Liver Enzyme Activities after Low-Dose Trilostane in Dogs with Hyperadrenocorticism
por: Tinted, Nannicha, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fgqkof1136q4192gcp6mgkuvla